BLAKE ROSEBERRY: Open Payments
NPI 1932810751 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$111 in 7 payments from 6 companies in 2025. Trend: 2023 $288 · 2024 $450 · 2025 $111
Food & beverage: $111
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 1 | $25 |
| Boston Scientific Corporation | 1 | $19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $18 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $16 |
Products named: OPSYNVI, EMBLEM MRI S-ICD, LifeVest, LEQVIO, ELIQUIS, CLEVIPREX.
Industry payments across IN — which companies pay providers there.
